Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid Tumors
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00049608 |
|
Recruitment Status :
Terminated
(Principal investigator [PI] has left institution.)
First Posted : January 27, 2003
Last Update Posted : June 19, 2013
|
Sponsor:
National Center for Complementary and Integrative Health (NCCIH)
Collaborator:
National Cancer Institute (NCI)
Information provided by:
National Cancer Institute (NCI)
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Primary Completion Date : | No date given |
| Actual Study Completion Date : | August 2011 |
Publications of Results:
Mansky PJ, Wallerstedt DB, Sannes T, et al.: NCCAM/NCI phase I study of mistletoe extract and gemcitabine in patients with advanced solid tumors. [Abstract] J Clin Oncol 28 (Suppl 15): A-2559, 2010.